Study guide

8.2 Admission Wound Screening & Present on Admission (POA) Documentation

NAWCCB WCC Wound Care Certified Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

About the NAWCCB WCC Exam How to Use This Study Guide

2 Assessment: Skin & Tissue Foundations

1.1 Skin Anatomy, Physiology, and Barrier Function 1.2 Phases of Wound Healing & Cellular Events 1.3 Acute vs. Chronic Wounds & Etiology Classification 1.4 TIME and MEASURE Assessment Frameworks 1.5 Wound Bed Tissue Types & Periwound Assessment 1.6 Pain Assessment: Scales, Wound Pain Types, and Procedural Analgesia 1.7 Psychosocial History, Cognitive Status, and Functional Assessment 1.8 Skin Integrity Across the Lifespan: Neonatal, Pediatric, Adult, and Geriatric

3 Assessment: Diagnostic Tools & Risk Assessment

2.1 Vascular Assessment: ABI, TcPO2, and Arterial/Venous Doppler 2.2 Neuropathy & Monofilament Testing in Diabetic Patients 2.3 Pressure Injury Risk Assessment: Braden Scale Subscales & Scoring 2.4 NPIAP Pressure Injury Staging (Stages 1-4, Unstageable, DTPI) 2.5 Exudate Characterization, Biofilm (NERDS/STONEES), & Wound Culture 2.6 Laboratory Interpretation in Wound Care: Albumin, Prealbumin, ESR, A1C, CBC, and CMP 2.7 Risk Assessment Instruments Beyond Braden: Norton, Braden Q, Braden QD, Wagner, and University of Texas

4 Treatment: Dressing Selection & Debridement Modalities

3.1 Principles of Dressing Selection by Exudate & Moisture Balance 3.2 High-Absorbency Dressings: Alginates, Hydrofibers, and Foams 3.3 Barrier & Hydrating Dressings: Hydrocolloids, Transparent Films, and Hydrogels 3.4 Antimicrobial & Biofilm Dressings: Silver, Cadexomer Iodine, and Honey 3.5 Debridement Modalities: Sharp, Enzymatic, Autolytic, Mechanical, & Biosurgical

5 Treatment: Advanced Therapies & Specialized Management

4.1 Negative Pressure Wound Therapy (NPWT) Indications, Settings, & Precautions 4.2 Compression Therapy Protocols & ABI Safety Cutoffs 4.3 DFU Off-loading Hierarchy: TCC, RCW, and Therapeutic Footwear 4.4 Support Surfaces, Microclimate Control, & Repositioning Protocols 4.5 Advanced Biologics, Cellular/Tissue Products (CTPs), & HBOT

6 Reevaluation & Wound Healing Trajectory

5.1 Healing Trajectory Benchmarks & Percent Area Reduction (PAR) 5.2 Serial Wound Measurement, Depth Profiling, & Digital Photography 5.3 Treatment Plan Reassessment & Non-Healing Wound Escalation Triggers 5.4 Biofilm Progression & Systemic Infection Re-evaluation 5.5 Palliative Wound Management: Odor, Exudate, and Pain Control 5.6 Validated Healing Instruments: The PUSH Tool, BWAT, and Evaluating Adherence

7 Risk Reduction & Prevention Strategies

6.1 Pressure Injury Prevention: Bundles, Turning Schedules, & Heel Floating 6.2 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis (IAD) 6.3 Infection Control, Contact Precautions, & Environmental Hygiene 6.4 Prevention of Skin Tears & Medical Adhesive-Related Skin Injuries (MARSI) 6.5 Diabetic & Venous Ulcer Recurrence Prevention Protocols 6.6 At-Risk Populations: Spinal Cord Injury, Stroke, Critical Care, and Cognitive Impairment

8 Patient & Caregiver Education

7.1 Patient & Caregiver Wound Care Teaching & Self-Management 7.2 Diabetic Foot Self-Inspection & Footwear Education 7.3 Nutritional Assessment & Dietary Interventions for Wound Healing 7.4 Off-loading Compliance & Patient Mobility Education 7.5 Recognizing Complications, Infection Signs, & When to Seek Care 7.6 Educating the Interprofessional Team & Developing Educational Media

9 Administration & Program Management

8.1 Wound Care Documentation Standards & Clinical Records 8.2 Admission Wound Screening & Present on Admission (POA) Documentation 8.3 Interdisciplinary Team Roles & Clinical Care Coordination 8.4 Quality Improvement Metrics & HAPI Tracking Programs 8.5 Wound Care Formulary Management & Resource Utilization

10 Legal, Ethical, & Scope of Practice

9.1 Informed Consent, Treatment Refusal, & Autonomy in Wound Care 9.2 HIPAA Compliance & Clinical Photography Privacy Standards 9.3 Scope of Practice Across WCC-Eligible Professions (RN, LPN, PT, OT, DPM, MD/DO, PA) 9.4 HAPI Malpractice Liability & Documentation Defense 9.5 Ethical Considerations in Non-Healing Wounds & End-of-Life Skin Care 9.6 Regulatory Compliance, Coding Standards, & Audit Protection

8.2 Admission Wound Screening & Present on Admission (POA) Documentation

Key Takeaways Explain This Topic AI

A comprehensive head-to-toe skin assessment must be completed and documented within 24 hours of admission to establish baseline skin integrity and identify Present on Admission (POA) wounds.

Under Centers for Medicare & Medicaid Services (CMS) rules, Stage 3, Stage 4, and Unstageable pressure injuries not documented as POA are classified as Hospital-Acquired Conditions (HACs), triggering loss of higher Diagnosis-Related Group (DRG) reimbursement.

The Braden Scale evaluates pressure injury risk across 6 subscales (Sensory Perception, Moisture, Activity, Mobility, Nutrition, Friction/Shear) totaling scores from 6 to 23, where scores ≤12 indicate high risk.

Clinical differentiation between pressure injuries and moisture-associated skin damage (MASD) is mandatory: pressure injuries present over bony prominences with distinct margins, while MASD presents as diffuse, shallow erythema in skin folds or perineum.

High-stage pressure injuries identified at admission require a two-clinician physical verification protocol and immediate physician countersignature to survive regulatory audit.

Last updated: August 2026

Admission Wound Screening & Present on Admission (POA) Documentation

Baseline skin assessment performed immediately upon patient admission is critical for establishing clinical risk, initiating preventative care bundles, and complying with stringent healthcare finance regulations. The Centers for Medicare & Medicaid Services (CMS) and private third-party payers enforce rigid mandates regarding Present on Admission (POA) documentation to distinguish pre-existing skin lesions from Hospital-Acquired Pressure Injuries (HAPIs) .

CMS Present on Admission (POA) Mandates & Financial Impact

Under the Deficit Reduction Act of 2005 and the Inpatient Prospective Payment System (IPPS), CMS designated Stage 3, Stage 4, and Unstageable pressure injuries as preventable Hospital-Acquired Conditions (HACs) . If a severe pressure injury develops during an inpatient admission and was not explicitly documented as present upon admission, hospitals forfeit the secondary Diagnosis-Related Group (DRG) financial adjustment.

CMS POA Indicator Designations

When coding inpatient diagnoses, clinicians and medical coders must assign one of four POA indicators to every identified wound:

Y (Yes): Present at the time of order for inpatient admission. Full reimbursement eligibility maintained.

N (No): Not present at the time of order for inpatient admission (Hospital-Acquired). Secondary DRG payment adjustment denied; facility absorbs all added treatment costs.

U (Unknown): Documentation insufficient to determine if condition was present on admission. Treated as "No" for financial penalties.

W (Clinically Undetermined): Provider is clinically unable to determine if condition was present on admission. Exempt from HAC payment reduction.

The 24-Hour Regulatory Window

To legally establish a wound as POA (Indicator Y), a qualified clinician must perform and document a complete head-to-toe physical skin assessment within 24 hours of inpatient admission (or transfer between acute units). If a pressure injury is discovered on day 2 or later without initial 24-hour documentation, CMS defaults the assignment to N (No) , classifying it as a facility-acquired injury.

Standardized Risk Assessment: The Braden Scale

Baseline skin screening requires quantifying pressure injury susceptibility using validated clinical prediction tools. The Braden Scale for Predicting Pressure Sore Risk is the most widely adopted framework in acute and long-term care.

The Six Braden Subscales

Each subscale is scored from 1 to 4 (except Friction and Shear, scored 1 to 3):

Sensory Perception (1–4): Ability to respond meaningfully to pressure-related discomfort.

Moisture (1–4): Degree to which skin is exposed to moisture from perspiration, urine, or feces.

Activity (1–4): Degree of physical activity (bedfast, chairfast, walks occasionally/frequently).

Mobility (1–4): Ability to change and control body position.

Nutrition (1–4): Usual food intake pattern (very poor, probably inadequate, adequate, excellent).

Friction and Shear (1–3): Assistance required for moving in bed or chair (problem, potential problem, no apparent problem).

Risk Stratification Cutoffs & Action Levels

Total Braden scores range from 6 to 23 . Lower scores indicate higher pressure injury vulnerability: Score ≤ 9 : Very High Risk Score 10 − 12 : High Risk Score 13 − 14 : Moderate Risk Score 15 − 18 : Mild Risk Score 19 − 23 : No Current Risk \begin{aligned}

  • \text{Score } \le 9 &: \text{ Very High Risk} \\
  • \text{Score } 10 - 12 &: \text{ High Risk} \\
  • \text{Score } 13 - 14 &: \text{ Moderate Risk} \\
  • \text{Score } 15 - 18 &: \text{ Mild Risk} \\
  • \text{Score } 19 - 23 &: \text{ No Current Risk}

\end{aligned} Score ≤ 9 Score 10 − 12 Score 13 − 14 Score 15 − 18 Score 19 − 23 ​ : Very High Risk : High Risk : Moderate Risk : Mild Risk : No Current Risk ​

Clinical Rule: A Braden score of 18 or below triggers immediate implementation of a standardized Pressure Injury Prevention (PIP) bundle, including Q2H repositioning schedules, pressure-redistributing support surfaces, barrier creams, and nutritional consultation.

Differential Diagnosis at Admission

Misidentifying non-pressure skin breakdown as a pressure injury distorts quality metrics and causes inappropriate treatment selection. Clinicians must differentiate pressure injuries from other common dermatological conditions at admission.

Pressure Injury vs. Moisture-Associated Skin Damage (MASD)

Pressure Injury: Located directly over a bony prominence (sacrum, ischium, heel, trochanter) or beneath a medical device; exhibits clear, circumscribed margins; depth varies from partial-thickness to full-thickness muscle/bone exposure.

Incontinence-Associated Dermatitis (IAD / MASD): Located in skin folds, perineum, perianal region, or buttocks; diffuse, irregular, non-circumscribed erythema; shallow epidermal erosion without true crater formation; often presents with kissing lesions on opposing skin folds.

Differential Skin Breakdown Summary

Intertriginous Dermatitis (ITD): Frictional moisture damage within deep skin folds (inframammary, abdominal pannus, inguinal).

Skin Tears: Traumatic wounds caused by shear, friction, or blunt force separating the epidermis from dermis; classified using the STAR or ISTAP system.

Kennedy Terminal Ulcer (KTU): A specific subtype of pressure injury that develops acutely in dying patients due to multi-organ failure and cutaneous hypoperfusion; typically shaped like a pear, butterfly, or horseshoe on the sacrum, progressing rapidly despite optimal prevention.

Admission Documentation Workflow & Verification Protocols

To ensure regulatory compliance and survive clinical audits, facilities must enforce a structured admission workflow:

Independent Skin Inspection: Inspect every anatomical region, explicitly examining under medical devices (tracheostomy ties, oxygen tubing, catheters, cervical collars, splints).

Two-Clinician Verification Protocol: When a Stage 3, Stage 4, Unstageable, or Deep Tissue Pressure Injury (DTPI) is identified during admission screening, a second licensed nurse or WCC specialist must independently verify the staging and anatomical extent.

Photographic Evidence Protocol: Take baseline photographs within 24 hours of admission adhering to HIPAA guidelines, displaying the patient ID sticker, date stamp, metric measuring tape, and anatomic location marker.

Physician Counter-signature: Provider progress notes must document the pre-existing nature of the wound, anatomical stage, and etiology within 24–48 hours of admission to substantiate the POA Indicator Y designation.

POA Indicator Description Financial Impact on Facility Clinical Documentation Requirement

Y (Yes) Condition present at inpatient admission order Full DRG reimbursement; no HAC penalty Documented skin screening within 24 hours of admission

N (No) Condition NOT present at admission (HAPI) Loss of higher DRG payment; facility absorbs costs Injury discovered after 24 hrs without initial POA entry

U (Unknown) Documentation insufficient to determine POA status Treated as "No"; payment reduction applied Incomplete admission skin assessment or vague notes

W (Undetermined) Clinically impossible to determine POA status Exempt from HAC financial penalty Detailed provider note explaining clinical impossibility

Loading diagram... Admission Skin Screening & POA Risk Stratification Workflow